Read article – Quotes Genevra Murray, research scientist at The Dartmouth Institute for Health Policy and Clinical Practice, who collaborated with colleagues from the University of California Berkeley and the University of North Carolina at Chapel Hill on research that found that accountable care organizations have major challenges integrating social services with medical care, including a lack of data on their patients’ social needs and the capabilities of community partners. “Policies that could facilitate the integration of social determinants include providing sustainable funding, implementing local and regional networking initiatives to facilitate partnership development, and developing standardized data on community-based organizations’ services and quality to aid providers that seek partners,” says Murray.
In the News
Read article – Quotes Brooke Judd, assistant professor of medicine and psychiatry, in an article that examines the treatment options available for people who suffer from sleep disorders.
Read article – Quotes Michael Sateia, active emeritus professor of psychiatry, in an article that examines the benefits and risks of sleeping pills.
Read article – Quotes John Batsis, associate professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, who is a member of a team of researchers from Dartmouth-Hitchcock and the University of Massachusetts Boston who have received a four-year $1.2 million grant from the National Institute on Aging to develop a system that would use machine and deep learning techniques to detect changes in speech patterns to determine if someone is a risk of developing dementia or Alzheimer’s. “Alzheimer’s disease and related dementias are a major public health concern that lead to high health costs, risk of nursing home placement, and place an inordinate burden on the whole family,” Batsis said. “The ability to plan in the early stages of the disease is essential for initiating interventions and providing support systems to improve patients’ everyday function and quality of life.”
Read article – Quotes Elizabeth Talbot, professor of medicine, in an article about the prevalence of the flu in the United States, and how to protect against it. Talbot says that people should wash their hands frequently, sneeze or cough into the crook of their elbow and avoid contact with ill people. “There are a lot of things we can do in a very routine way to stay healthier,” Talbot said.
Read article – A news brief about a study co-authored by Ashleigh King, TDI ’18, research project coordinator at The Dartmouth Institute for Health Policy and Clinical Practice, that found that pharmaceutical companies spend more on doctor office visits from salespeople offering free samples—known as detailing—than any other marketing.
Read article – Cites a 2018 Dartmouth Atlas of Healthcare finding that patients nearing death in New Jersey undergo the nation’s most aggressive medical treatments, often at odds with the individual’s personal desires and high financial costs.
Read article – Quotes Elizabeth Talbot, professor of medicine, in an article about the quarantine measures being taken in China to curb the spread of coronavirus. Chinese authorities have indefinitely barred 50 million people from traveling and advised them to stay home to contain the rapidly spreading virus. “We would almost certainly not do any quarantine on the scope that China is doing now,” Talbot said of the United States’ methods for handling disease outbreaks. “We have a different cultural acceptance of restriction of our rights, and quarantine always bumps up against that.”
Read article – Highlights the “Drug Facts” box—a standardized, single-page format for conveying drug effectiveness and risk of harm—developed by researchers Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, and the late Geisel professor Lisa Schwartz.
Read article – Features a study conducted by researchers at Dartmouth that found that drugmakers promoting their drugs directly to physicians affect prescribing quality and can raise drug prices, but the practice is more commonplace in smaller health systems with fewer physicians.